ANDA 77551, held by Sandoz. Ondansetron Hydrochloride.
As of Nov 16, 2026, ANDA 77551 (Ondansetron Hydrochloride Preservative Free), held by Sandoz, was first approved by FDA on Jun 27, 2007, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 27, 2007 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ondansetron Hydrochloride Preservative FreeEQ 2MG BASE/ML · injectable;injection | Ondansetron Hydrochloride | Rx |
| Jan 20, 2015 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 20, 2015 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 8, 2013 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 8, 2013 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jun 27, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters